title: Standard- vs high-dose clopidogrel after percutaneous coronary intervention.
authors.forename: Young-Hoon
authors.initials: YH
authors.lastname: Jeong
authors.forename: Yongwhi
authors.initials: Y
authors.lastname: Park
authors.forename: In-Suk
authors.initials: IS
authors.lastname: Kim
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000401:mortality; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D004305:Dose-Response Relationship, Drug; D020022:Genetic Predisposition to Disease; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D015539:Platelet Activation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D015203:Reproducibility of Results; D012306:Risk; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine